Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC <i>via</i> Mediation of PI3K/Akt Signaling Pathway.

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway.

Yu, Huiqing; Tian, Ling; Yang, Liejun; Liu, Shihong; Wang, Sixiong; Gong, Juan.

Afiliação

Yu H; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Tian L; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Yang L; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Liu S; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Wang S; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Gong J; Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.

Front Oncol ; 11: 620213, 2021.

Article em En | MEDLINE | ID: mdl-33816250